Sponsors

Company Profile

MBC Pharma, Inc.

Drug Discovery
Cancer
Other
Metabolic bone diseases, including osteoporosis and Paget's Disease

6610 Gunpark Dr
Suite 202
Boulder, CO 80301
USA
www.mbcpharma.com 		Incorporated in 1996
3 Employees 		Privately Held

This Year's Highlights

  • Raised $1.1 million seed money in 2005
  • Selected to present at Biowest 2005 Venture Showcase. Follow up interest resulted and venture capital pursuit is underway.
  • Awarded 3 STTR grants from NIH for cancer and osteoporosis applications of technology. Leveraged these funds with seed money to efficiently establish potential of technology and clear proof of concept, with two clear preclinical leads.

Anticipated Highlights

  • Closure of Series A venture financing by Q3-06 and pharma deal by Q4-06
  • Follow up STTR and SBIR grants anticipated during 2006

Corporate Mission

MBC Pharma?s mission is become a successful biotechnology company that discovers and develops best-in-class drugs for critical bone diseases. With proprietary drugs discovered or developed at MBC Pharma, we strive to improve the lives of patients suffering from or at risk for bone diseases, while providing high rewards for our shareholders.